share_log

Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $40

Benzinga ·  May 3 07:02

Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $39 to $40.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment